SCHEMBL7490127

SCHEMBL7490127

CCOC(=O)COc1cccc2c1CCC[C@@H]2N1CCC[C@H]1c1nc(-c2ccccc2)c(-c2ccccc2)o1

nearest known ligand 0.79

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 9/20 0.79
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TP53 P04637 1/20 0.37
KMT2A Q03164 3/20 0.36
PPARD Q03181 1/20 0.35
NR4A2 P43354 2/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
MEN1 O00255 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 1/20 0.34
GABRA5 P31644 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7490049 1.00 PTGIR (0.79) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7485719 1.00 PTGIR (0.79) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7483521 1.00 PTGIR (0.79) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7485254 1.00 PTGIR (0.79) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7494834 0.98 PTGIR (0.75) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7498945 0.97 PTGIR (0.74) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7494915 0.97 PTGIR (0.74) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7493823 0.95 PTGIR (0.71) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7492525 0.95 PTGIR (0.71) PTGIRALDH1A1KDM4EMAPTHPGD
SCHEMBL7487580 0.90 PTGIR (0.86) PTGIRPPARDNR4A2RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842161-B1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2002-09-18 EP disclosed
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed